Fatty acylated caveolin-2 is a substrate of insulin receptor tyrosine kinase for insulin receptor substrate-1-directed signaling activation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 5, 2015, Pages 1022-1034

  Kwon, Hayeong ^a   Lee, Jaewoong ^a   Jeong, Kyuho ^a   Jang, Donghwan ^a   Pak, Yunbae ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Caveolin 2; Cell proliferation and survival; Fatty acylation; Glucose uptake; Insulin receptor substrate 1; Insulin receptor tyrosine kinase

Indexed keywords

CAVEOLIN 2; CYSTEINE; GLUCOSE; GLYCINE; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; FATTY ACID; INSULIN; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR TYROSINE KINASE; IRS1 PROTEIN, RAT; MITOGENIC AGENT; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN TYROSINE KINASE;

ACYLATION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME MECHANISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; MYRISTYLATION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; BIOCATALYSIS; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENZYME SPECIFICITY; GENE SILENCING; INTRACELLULAR SPACE; LIPOYLATION; METABOLISM; MOLECULAR GENETICS; MOUSE; PHOSPHORYLATION; PROTEIN MOTIF; PROTEIN TRANSPORT;

ACYLATION; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BIOCATALYSIS; CAVEOLIN 2; CELL LINE; CYSTEINE; FATTY ACIDS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTRACELLULAR SPACE; LIPOYLATION; MICE; MITOGENS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; RATS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 84923166140     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.02.002     Document Type: Article

References (55)

1. Ramalingam L., Oh E., Thurmond D.C. Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates. Cell. Mol. Life Sci. 2013, 70:2815-2834.
2. Nystrom F.H., Chen H., Cong L.N., Li Y., Quon M.J. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol. Endocrinol. 1999, 13:2013-2024.
3. Yamamoto M., Toya Y., Schwencke C., Lisanti M.P., Myers M.G., Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 1998, 273:26962-26968.
4. Couet J., Sargiacomo M., Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 1997, 272:30429-30438.
5. Kimura A., Mora S., Shigematsu S., Pessin J.E., Saltiel A.R. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J. Biol. Chem. 2002, 277:30153-30158.
6. Mastick C.C., Saltiel A.R. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J. Biol. Chem. 1997, 272:20706-20714.
7. Oshikawa J., Otsu K., Toya Y., Tsunematsu T., Hankins R., Kawabe J., Minamisawa S., Umemura S., Hagiwara Y., Ishikawa Y. Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12670-12675.
8. Byrne D.P., Dart C., Rigden D.J. Evaluating caveolin interactions: do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif?. PLoS One 2012, 7:e44879.
9. Collins B.M., Davis M.J., Hancock J.F., Parton R.G. Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions?. Dev. Cell 2012, 23:11-20.
10. Kim S., Pak Y. Caveolin-2 regulation of the cell cycle in response to insulin in Hirc-B fibroblast cells. Biochem. Biophys. Res. Commun. 2005, 330:88-96.
11. Kwon H., Jeong K., Pak Y. Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis. J. Cell. Mol. Med. 2009, 13:1549-1564.
12. Kwon H., Jeong K., Hwang E.M., Park J.Y., Hong S.G., Choi W.S., Pak Y. Caveolin-2 regulation of STAT3 transcriptional activation in response to insulin. Biochim. Biophys. Acta 2009, 1793:1325-1333.
13. Kwon H., Pak Y. Prolonged tyrosine kinase activation of insulin receptor by pY27-caveolin-2. Biochem. Biophys. Res. Commun. 2010, 391:49-55.
14. Kwon H., Jeong K., Hwang E.M., Park J.Y., Pak Y. A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2. J. Cell. Mol. Med. 2011, 15:888-908.
15. Jeong K., Kwon H., Lee J., Jang D., Hwang E.M., Park J.Y., Pak Y. Rab6-mediated retrograde transport regulates inner nuclear membrane targeting of caveolin-2 in response to insulin. Traffic 2012, 13:1218-1233.
16. Kwon H., Lee J., Jeong K., Jang D., Pak Y. A novel actin cytoskeleton-dependent noncaveolar microdomain composed of homo-oligomeric caveolin-2 for activation of insulin signaling. Biochim. Biophys. Acta 2013, 1833:2176-2189.
17. Linder M.E., Deschenes R.J. Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell Biol. 2007, 8:74-84.
18. Alland L., Peseckis S.M., Atherton R.E., Berthiaume L., Resh M.D. Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization. J. Biol. Chem. 1994, 269:16701-16705.
19. Neumann-Giesen C., Falkenbach B., Beicht P., Claasen S., Lüers G., Stuermer C.A., Herzog V., Tikkanen R. Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem. J. 2004, 378:509-518.
20. Zlatkine P., Mehul B., Magee A.I. Retargeting of cytosolic proteins to the plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J. Cell Sci. 1997, 110:673-679.
21. Dietzen D.J., Hastings W.R., Lublin D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 1995, 270:6838-6842.
22. Lee H., Woodman S.E., Engelman J.A., Volonté D., Galbiati F., Kaufman H.L., Lublin D.M., Lisanti M.P. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14). J. Biol. Chem. 2001, 276:35150-35158.
23. Pak Y., Paule C.R., Bao Y.D., Huang L.C., Larner J. Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7759-7763.
24. Student A.K., Hsu R.Y., Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 1980, 255:4745-4750.
25. Gonzalez E., Fliera E., Mollea D., Accilib D., McGrawa T.E. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10162-10167.
26. Karylowski O., Zeigerer A., Cohen A., McGraw T.E. GLUT4 is retained by an intracellular cycle of vesicle formation and fusion with endosomes. Mol. Biol. Cell 2004, 15:870-882.
27. Tulloch L.B., Howie J., Wypijewski K.J., Wilson C.R., Bernard W.G., Shattock M.J., Fuller W. The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation. J. Biol. Chem. 2011, 286:36020-36031.
28. Nakata M., Nagasaka S., Kusaka I., Matsuoka H., Ishibashi S., Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia 2006, 49:1881-1892.
29. Nam W.S., Park K.M., Park J.W. RNA interference targeting cytosolic NADP(+)-dependent isocitrate dehydrogenase exerts anti-obesity effect in vitro and in vivo. Biochim. Biophys. Acta 2012, 1822:1181-1188.
30. Yamada K., Saito M., Matsuoka H., Inagaki N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nat. Protoc. 2007, 2:753-762.
31. Lee H., Park D.S., Wang X.B., Scherer P.E., Schwartz P.E., Lisanti M.P. Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. J. Biol. Chem. 2002, 277:34556-34567.
32. Wang X.B., Lee H., Capozza F., Marmon S., Sotgia F., Brooks J.W., Campos-Gonzalez R., Lisanti M.P. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27). Biochemistry 2004, 43:13694-13706.
33. Cao H., Courchesne W.E., Mastick C.C. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J. Biol. Chem. 2002, 277:8771-8774.
34. Takeuchi K., Morizane Y., Kamami-Levy C., Suzuki J., Kayama M., Cai W., Miller J.W., Vavvas D.G. AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells. J. Biol. Chem. 2013, 288:20581-20591.
35. Gustafson T.A., He W., Craparo A., Schaub C.D., O'Neill T.J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate-1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 1995, 15:2500-2508.
36. Ebina Y., Araki E., Taira M., Shimada F., Mori M., Craik C.S., Siddle K., Pierce S.B., Roth R.A., Rutter W.J. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:704-708.
37. Zhou F., Xue Y., Yao X., Xu Y. CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics 2006, 22:894-896.
38. Cohen A.W., Combs T.P., Scherer P.E., Lisanti M.P. Role of caveolin and caveolae in insulin signaling and diabetes. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E1151-E1160.
39. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 1998, 273:5419-5422.
40. Parton R.G., Hanzal-Bayer M., Hancock J.F. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 2006, 119:787-796.
41. Farazi T.A., Waksman G., Gordon J.I. The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 2001, 276:39501-39504.
42. Korycka J., Łach A., Heger E., Bogusławska D.M., Wolny M., Toporkiewicz M., Augoff K., Korzeniewski J., Sikorski A.F. Human DHHC proteins: a spotlight on the hidden player of palmitoylation. Eur. J. Cell Biol. 2012, 91:107-117.
43. Greaves J., Chamberlain H. DHHC palmitoyl transferases: substrate interaction and (patho)physiology. Trends Biochem. Sci. 2011, 36:245-253.
44. Zeidman R., Jackson C.S., Magee A.I. Protein acyl thioesterases. Mol. Membr. Biol. 2009, 26:32-41.
45. Kong E., Peng S., Chandra G., Sarkar C., Zhang Z., Bagh M.B., Mukherjee A.B. Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43. J. Biol. Chem. 2013, 288:9112-9125.
46. Fong A., Garcia E., Gwynn L., Lisanti M.P., Fazzari M.J., Li M. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am. J. Clin. Pathol. 2003, 120:93-100.
47. Lee S., Kwon H., Jeong K., Pak Y. Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression. Int. J. Oncol. 2011, 38:1395-1402.
48. Racine C., Bélanger M., Hirabayashi H., Boucher M., Chakir J., Couet J. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 1999, 255:580-586.
49. Scherer P.E., Lewis R.Y., Volonte D., Engelman J.A., Galbiati F., Couet J., Kohtz D.S., van Donselaar E., Peters P., Lisanti M.P. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 1997, 272:29337-29346.
50. Shatseva T., Lee D.Y., Deng Z., Yang B.B. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J. Cell Sci. 2011, 124:2826-2836.
51. Gómez-Ruiz A., de Miguel C., Campión J., Martínez J.A., Milagro F.I. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet. FEBS Lett. 2009, 583:3259-3264.
52. López I.P., Milagro F.I., Martí A., Moreno-Aliaga M.J., Martínez J.A., De Miguel C. Gene expression changes in rat white adipose tissue after a high-fat diet determined by differential display. Biochem. Biophys. Res. Commun. 2004, 318:234-239.
53. López I.P., Milagro F.I., Marti A., Moreno-Aliaga M.J., Martinez J.A., De Miguel C. High-fat feeding period affects gene expression in rat white adipose tissue. Mol. Cell. Biochem. 2005, 275:109-115.
54. Fisher E., Schreiber S., Joost H.G., Boeing H., Döring F. A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk. J. Nutr. 2011, 141:177-181.
55. He A., Zhu L., Gupta N., Chang Y., Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 2007, 21:2785-2794.